Purpose

The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.

Conditions

Eligibility

Eligible Ages
Over 30 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Acute focal symptoms or signs of any duration associated with imaging, pathological, or other objective evidence of arterial infarction OR clinical evidence of cerebral, spinal cord, or retinal focal arterial ischemic injury based on symptoms persisting greater than or equal to 24 hours that occurred within 30 days prior to randomization - Index stroke is attributed to 70-99% stenosis (or flow gap on MRA) of a major intracranial artery (carotid artery, middle cerebral artery (M1 or M2), vertebral artery (V4), basilar artery, posterior cerebral artery (P1), or anterior cerebral artery (A1)) documented by CTA, MRA, or catheter angiography - Modified Rankin Scale score of ≤ 4, at time of consent - Ability to swallow pills - At least 30 years of age, inclusive, at time of consent - Subjects 30-49 years of age are required to meet at least ONE of the following additional criteria below to qualify for the study: 1. diabetes treated with insulin for at least 15 years 2. at least 2 of the following atherosclerotic risk factors: hypertension (BP > 140/90 or on antihypertensive therapy); dyslipidemia (LDL > 130 mg /dl or HDL < 40 mg/dl or fasting triglycerides > 150 mg/dl or on lipid lowering therapy); smoking; non-insulin dependent diabetes or insulin dependent diabetes of less than 15 years duration; any of the following vascular events occurring in a parent or sibling who was < 55 years of age for men or < 65 years of age for women at the time of the event: myocardial infarction, coronary artery bypass, coronary angioplasty or stenting, stroke, carotid endarterectomy or stenting, peripheral vascular surgery for atherosclerotic disease 3. personal history of any of the following: myocardial infarction, coronary artery bypass, coronary angioplasty or stenting, carotid endarterectomy or stenting, or peripheral vascular surgery for atherosclerotic disease 4. any stenosis of an extracranial carotid or vertebral artery, another intracranial artery, subclavian artery, coronary artery, iliac or femoral artery, other lower or upper extremity artery, mesenteric artery, or renal artery that was documented by non-invasive vascular imaging or catheter angiography and is considered atherosclerotic 5. aortic arch atheroma documented by non-invasive vascular imaging or catheter angiography 6. any aortic aneurysm documented by non-invasive vascular imaging or catheter angiography that is considered atherosclerotic - Negative pregnancy test in a female who has had any menses in the last 18 months and has not had surgery that would make her unable to become pregnant - Subject is willing and able to return for all follow-up evaluations required by the protocol - Subject is available by phone - Subject understands the purpose and requirements of the study and can make him/herself understood - Subject has provided informed consent (use of a LAR is not permitted)

Exclusion Criteria

  • Previous treatment of qualifying intracranial artery with a stent, angioplasty, or other mechanical device, including mechanical thrombectomy for the qualifying stroke, or plan to perform one of these procedures - Plan to perform concomitant endarterectomy, angioplasty or stenting of an extracranial vessel tandem to the symptomatic intracranial stenosis - Intracranial tumor (except meningioma) or any intracranial vascular malformation - Thrombolytic therapy within 24 hours prior to randomization - Progressive neurological signs within 24 hours prior to randomization - History of spontaneous non-traumatic intracranial hemorrhage (parenchymal, subarachnoid, subdural, epidural) - Intracranial arterial stenosis due to: arterial dissection; MoyaMoya disease; any known vasculitic disease; herpes zoster, varicella zoster or other viral vasculopathy; neurosyphilis; any other intracranial infection; any intracranial stenosis associated with CSF pleocytosis; radiation induced vasculopathy; fibromuscular dysplasia; sickle cell disease; neurofibromatosis; benign angiopathy of central nervous system; postpartum angiopathy; suspected vasospastic process; reversible cerebral vasoconstriction syndrome (RCVS); suspected recanalized embolus - Presence of any of the following unequivocal cardiac sources of embolism: chronic or paroxysmal atrial fibrillation, mitral stenosis, mechanical valve, endocarditis, intracardiac clot or vegetation, myocardial infarction within three months, left atrial spontaneous echo contrast - Known allergy or contraindication to aspirin, rivaroxaban, clopidogrel, or ticagrelor - Uncontrolled severe hypertension (systolic pressure > 180 mm Hg or diastolic pressure > 115 mm Hg), active peptic ulcer disease, major systemic hemorrhage within 30 days prior to randomization, active bleed or bleeding diathesis, platelets < 100,000, hematocrit < 30, INR > 1.5, clotting factor abnormality that increases the risk of bleeding, current alcohol or substance abuse, severe liver impairment (AST or ALT > 3 x normal, cirrhosis), or CrCl < 15 mL/min or on dialysis - Major surgery (including stenting of any vessel; open femoral, aortic, or carotid surgery; or cardiac surgery) within previous 30 days prior to randomization or planned in the next 90 days after randomization - Any condition other than intracranial arterial stenosis that requires the subject to take any antithrombotic medication other than aspirin (NOTE: exceptions allowed for subcutaneous heparin or enoxaparin for deep vein thrombosis (DVT) prophylaxis) - Dementia or psychiatric problem that prevents the subject from following an outpatient program reliably - Co-morbid conditions that may limit survival to less than 12 months - Pregnancy or of childbearing potential and unwilling to use contraception for the duration of this study, or currently breastfeeding - Current or anticipated concomitant oral or intravenous therapy with strong CYP3A4 inhibitors or CYP3A4 substrates that cannot be stopped for the course of this study - Enrollment in another study that would conflict with the current study

Study Design

Phase
Phase 3
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description
1:1:1 treatment allocation

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Experimental Arm: Ticagrelor and Aspirin
Ticagrelor (180mg loading dose, then 90mg twice daily) and aspirin (81mg daily)
  • Drug: Ticagrelor + Aspirin
    ticagrelor (180 mg loading dose, then 90mg twice daily) and aspirin (81mg daily)
    Other names:
    • Brilinta
  • Other: Risk Factor Management
    Risk factors for stroke (LDL, blood pressure, non-HDL cholesterol, diabetes, smoking, weight, and physical activity) will be monitored and managed.
Active Comparator
Standard of Care Arm: Clopidogrel and Aspirin
Clopidogrel (600mg loading dose, then 75mg once daily) and aspirin (81mg daily)
  • Drug: Clopidogrel + Aspirin
    clopidogrel (600mg loading dose, then 75mg daily) and aspirin (81mg daily)
    Other names:
    • Plavix
  • Other: Risk Factor Management
    Risk factors for stroke (LDL, blood pressure, non-HDL cholesterol, diabetes, smoking, weight, and physical activity) will be monitored and managed.
Experimental
Experimental Arm: Rivaroxaban and Aspirin
Rivaroxaban (2.5mg twice daily) and aspirin (81mg daily)
  • Drug: Rivaroxaban + Aspirin
    low dose rivaroxaban (2.5mg twice daily) and aspirin (81mg daily)
    Other names:
    • Xarelto
  • Other: Risk Factor Management
    Risk factors for stroke (LDL, blood pressure, non-HDL cholesterol, diabetes, smoking, weight, and physical activity) will be monitored and managed.

Recruiting Locations

University of Alabama Hospital
Birmingham 4049979, Alabama 4829764 35233
Contact:
Tammy Davis
trdavis@uabmc.edu

University of South Alabama University Hospital
Mobile 4076598, Alabama 4829764 36604
Contact:
Zane Patterson
zpatterson@health.southalabama.edu

St. Joseph's Hospital and Medical Center
Phoenix 5308655, Arizona 5551752 85013
Contact:
Jaimi Jones
jaimi.jones@commonspirit.org

Mayo Clinic
Phoenix 5308655, Arizona 5551752 85054
Contact:
Neil Santos
Santos.Neil@mayo.edu

Mercy San Juan Medical Center
Carmichael 5334336, California 5332921 95608
Contact:
Danielle Hornbuckle
danielle.hornbuckle@commonspirit.org

The Neuron Clinic - Chula Vista
Chula Vista 5336899, California 5332921 91910
Contact:
Daniel Arevalo
daniel@theneuronclinic.com

Kaiser Permanente Fontana Medical Center
Fontana 5349755, California 5332921 92335
Contact:
Kimberly Cortez
Kimberly.X.Cortez@kp.org

Long Beach Memorial Medical Center
Long Beach 5367929, California 5332921 90806
Contact:
En Fan (Sophia) Chou
echou2@memorialcare.org

Los Alamitos Medical Center
Los Alamitos 5368304, California 5332921 90720
Contact:
Richard Bailey
Richard.bailey@tenethealth.com

Kaiser Permanente Los Angeles Medical Center
Los Angeles 5368361, California 5332921 90027
Contact:
Dyanna Chung
Dyanna.X.Chung@kp.org

UC Davis Medical Center
Sacramento 5389489, California 5332921 95817
Contact:
Andrea Diaz-Sevilla
amdiazsevilla@ucdavis.edu

Providence Little Company of Mary Medical Center Torrance
Torrance 5403022, California 5332921 90503
Contact:
Sherine Elsayegh
sherine.elsayegh@providence.org

University of Colorado Hospital
Aurora 5412347, Colorado 5417618 80045
Contact:
Allison Kopp
allison.kopp@cuanschutz.edu

St. Mary's Medical Center
Grand Junction 5423573, Colorado 5417618 81501
Contact:
Chelsea Lorimor
Chelsea.Lorimor@imail.org

Hartford Hospital
Hartford 4835797, Connecticut 4831725 06102
Contact:
Laura Grenier
Laura.grenier@hhchealth.org

Yale New Haven Hospital
New Haven 4839366, Connecticut 4831725 06520
Contact:
Michael Kampp
michael.kampp@yale.edu

MedStar Washington Hospital Center
Washington D.C. 4140963, District of Columbia 4138106 20010
Contact:
Wesley McClure
wesley.mcclure@medstar.net

Morton Plant Hospital
Clearwater 4151316, Florida 4155751 33756
Contact:
Tara McTigue
tara.mctigue@baycare.org

Broward Health Medical Center
Fort Lauderdale 4155966, Florida 4155751 33316
Contact:
Shirley Cheraime
scheraime@browardhealth.org

UF Health Shands Hospital
Gainesville 4156404, Florida 4155751 32608
Contact:
Amy Holland
amy.holland@ufl.edu

Baptist Medical Center Jacksonville
Jacksonville 4160021, Florida 4155751 32207
Contact:
Teresa Nicol
Teresa.Nicol@bmcjax.com

Mayo Clinic
Jacksonville 4160021, Florida 4155751 32224
Contact:
Amy Hubbard
hubbard.amy2@mayo.edu

Jackson Memorial Hospital
Miami 4164138, Florida 4155751 33136
Contact:
Andrea Escobar
a.escobar1@med.miami.edu

Cleveland Clinic Tradition Hospital
Port Saint Lucie 4169171, Florida 4155751 34987
Contact:
Angelic Gamez
GamezA3@ccf.org

Emory University Hospital
Atlanta 4180439, Georgia 4197000 30303
Contact:
Alicia Escobar Moore
alicia.escobar.moore@emory.edu

Grady Memorial Hospital
Atlanta 4180439, Georgia 4197000 30303
Contact:
Alicia Escobar Moore
alicia.escobar.moore@emory.edu

Memorial Hospital of Carbondale
Carbondale 4235193, Illinois 4896861 62901
Contact:
Heather Von Hagn
heather.vonhagn@sih.net

Rush University Medical Center
Chicago 4887398, Illinois 4896861 60612
Contact:
Henna McCoy
Henna_R_McCoy@rush.edu

University of Illinois Hospital
Chicago 4887398, Illinois 4896861 60612
Contact:
Luzy Rosales
luzr@uic.edu

University of Chicago Medical Center
Chicago 4887398, Illinois 4896861 60637
Contact:
Khalid Trad
khalid.trad@bsd.uchicago.edu

Evanston Hospital
Evanston 4891382, Illinois 4896861 60201
Contact:
May Aunaetitrakul
NAunaetitrakul@northshore.org

Javon Bea Hospital - Riverside
Rockford 4907959, Illinois 4896861 61114
Contact:
Frances Quinones
fquinones@mhemail.org

University of Kansas Hospital
Kansas City 4273837, Kansas 4273857 66160
Contact:
Margaret Houghton
mhoughton3@kumc.edu

Baptist Health Lexington
Lexington 4297983, Kentucky 6254925 40503
Contact:
Misty Burns
misty.burns@bhsi.com

Ochsner Medical Center - Main Campus
New Orleans 4335045, Louisiana 4331987 70121
Contact:
Jessica Henry
jehenry@ochsner.org

Massachusetts General Hospital
Boston 4930956, Massachusetts 6254926 02114
Contact:
Elaina Hill
ehill0@mgh.harvard.edu

Brigham and Women's Hospital
Boston 4930956, Massachusetts 6254926 02115
Contact:
Faina Rabinovich
Frabinovich@bwh.harvard.edu

Boston Medical Center
Boston 4930956, Massachusetts 6254926 02118
Contact:
Robert Araujo-Contreras
Robert.AraujoContreras@bmc.org

Beth Israel Deaconess Medical Center
Boston 4930956, Massachusetts 6254926 02215
Contact:
Elizabeth Heistand
eheistan@bidmc.harvard.edu

Henry Ford Hospital
Detroit 4990729, Michigan 5001836 48202
Contact:
Teresa Long
tlong10@hfhs.org

McLaren Flint
Flint 4992982, Michigan 5001836 48532
Contact:
Marci Roberts
marci.roberts@mclaren.org

McLaren Macomb
Mount Clemens 5002656, Michigan 5001836 48043
Contact:
Marci Roberts
Marci.Roberts@mclaren.org

Metro Health Hospital
Wyoming 5015618, Michigan 5001836 49519
Contact:
Garrett Hilbelink
garrett.hilbelink@umhwest.org

M Health Fairview Southdale Hospital
Edina 5025264, Minnesota 5037779 55414
Contact:
Nicole Degerman
deger018@umn.edu

Abbott Northwestern Hospital
Minneapolis 5037649, Minnesota 5037779 55407
Contact:
Kaitlin Lundell
Kaitlin.Lundell@allina.com

M Health Fairview University of Minnesota Medical Center
Minneapolis 5037649, Minnesota 5037779 55415
Contact:
Nicole Degerman
deger018@umn.edu

University of Mississippi Medical Center
Jackson 4431410, Mississippi 4436296 39216
Contact:
Maggie Smith
mjsmith2@umc.edu

University of Missouri Health Care
Columbia 4381982, Missouri 4398678 65212
Contact:
Andrea Bright
andrea.bright@health.missouri.edu

Barnes Jewish Hospital
St Louis 4407066, Missouri 4398678 62269
Contact:
Alyssa Hiserote
calyssa@wustl.edu

University of Nebraska Medical Center
Omaha 5074472, Nebraska 5073708 68198
Contact:
Katelyn Hilz
katelyn.hilz@unmc.edu

Cooper University Hospital
Camden 4501018, New Jersey 5101760 08103
Contact:
Lynne Kohler
kohler-lynne@cooperhealth.edu

Jersey Shore University Medical Center
Neptune City 5101687, New Jersey 5101760 07753
Contact:
Alexandria Nuwar
alexandria.nuwar@hmhn.org

University of New Mexico Hospital
Albuquerque 5454711, New Mexico 5481136 87106
Contact:
Jacquelyn Morales
JSMorales@salud.unm.edu

Kings County Hospital Center
Brooklyn 5110302, New York 5128638 11203
Contact:
Sarah Hobbs
hobbss3@nychhc.org

SUNY Downstate Medical Center
Brooklyn 5110302, New York 5128638 11203
Contact:
Nadege Gilles
nadege.gilles@downstate.edu

NYU Langone Hospital - Brooklyn
Brooklyn 5110302, New York 5128638 11220
Contact:
Maria Cotrina-Vidal
Maria.cotrina@nyulangone.org

Buffalo General Medical Center
Buffalo 5110629, New York 5128638 14202
Contact:
Annemarie Crumlish
ac35@buffalo.edu

North Shore University Hospital
Lake Success 5123853, New York 5128638 11042
Contact:
Siddharth Dholiya
sdholiya@northwell.edu

NYP Weill Cornell Medical Center
New York 5128581, New York 5128638 10021
Contact:
Lillie Lanphier
lil4023@med.cornell.edu

The Mount Sinai Hospital
New York 5128581, New York 5128638 10029
Contact:
Naresh Poondla
naresh.poondla@mssm.edu

NYP Columbia University Medical Center
New York 5128581, New York 5128638 10032
Contact:
Cynthia Martinez
cm3506@cumc.columbia.edu

Carolinas Medical Center
Charlotte 4460243, North Carolina 4482348 28207
Contact:
Anna Maria Swiatek
Anna.M.Helms@atriumhealth.org

Duke University Hospital
Durham 4464368, North Carolina 4482348 27710
Contact:
Megan Gonzalez
megan.gonzalez@duke.edu

Moses H. Cone Memorial Hospital
Greensboro 4469146, North Carolina 4482348 27405
Contact:
Jamil Ahmed
Jamil.Ahmed@gnr.clinic

ECU Health Medical Center
Greenville 4469160, North Carolina 4482348 27834
Contact:
Miriam Wood
Miriam.Wood@ecuhealth.org

Wake Forest Baptist Medical Center
Winston-Salem 4499612, North Carolina 4482348 27157
Contact:
Erika Bayne
ebayne@wakehealth.edu

Cleveland Clinic Akron General
Akron 5145476, Ohio 5165418 44307
Contact:
Debra Hudock
HudockD@ccf.org

Good Samaritan Hospital
Cincinnati 4508722, Ohio 5165418 45220
Contact:
Mehnaaz Ali
mehnaaz_ali@trihealth.com

University of Cincinnati Medical Center
Cincinnati 4508722, Ohio 5165418 45267
Contact:
Marchele Nowell-Bostic
nowellme@ucmail.uc.edu

UH Cleveland Medical Center
Cleveland 5150529, Ohio 5165418 44106
Contact:
Mary Andrews
mary.andrews@uhhospitals.org

Cleveland Clinic
Cleveland 5150529, Ohio 5165418 44195
Contact:
Heidi Poppendeck
poppenh@ccf.org

OSU Wexner Medical Center
Columbus 4509177, Ohio 5165418 43210
Contact:
Mohammad Hamed
mohammad.hamed@osumc.edu

Toledo Hospital
Toledo 5174035, Ohio 5165418 43606
Contact:
Melanie Pakulski
melanie.pakulski@promedica.org

Mercy St. Vincent Medical Center
Toledo 5174035, Ohio 5165418 43608
Contact:
Joseph Bandi
JBandi@mercy.com

OU Medical Center
Oklahoma City 4544349, Oklahoma 4544379 73104
Contact:
April Vaughan
April-Vaughan@ouhsc.edu

Jefferson Abington Hospital
Abington 5177773, Pennsylvania 6254927 19001
Contact:
Courtney Pratt
courtney.pratt@jefferson.edu

UPMC Hamot
Erie 5188843, Pennsylvania 6254927 16550
Contact:
Shawna Chylinski
Chylinskisj@upmc.edu

Hospital of the University of Pennsylvania
Philadelphia 4560349, Pennsylvania 6254927 19104
Contact:
Sophie Goldberg
sophie.goldberg@pennmedicine.upenn.edu

Thomas Jefferson University Hospital
Philadelphia 4560349, Pennsylvania 6254927 19107
Contact:
Latasha Adams
latasha.adams2@jefferson.edu

Temple University Hospital, Philadelphia
Philadelphia 4560349, Pennsylvania 6254927 19140
Contact:
Sandra Combs
sandra.combs@tuhs.temple.edu

UPMC Presbyterian Hospital
Pittsburgh 5206379, Pennsylvania 6254927 15213
Contact:
Emma Gyurisin
gyurisinek2@upmc.edu

Rhode Island Hospital
Providence 5224151, Rhode Island 5224323 02903
Contact:
Skylar Lewis
SLewis7@brownhealth.org

Medical University of South Carolina University Hospital
Charleston 4574324, South Carolina 4597040 29425
Contact:
Caitlan LeMatty
lemattyc@musc.edu

Prisma Health Richland Hospital
Columbia 4575352, South Carolina 4597040 29203
Contact:
Georgia Taylor
georgia.taylor@prismahealth.org

Prisma Health Greenville Memorial Hospital
Greenville 4580543, South Carolina 4597040 29605
Contact:
Sarah Boegel
sarah.boegel@prismahealth.org

Methodist University Hospital
Memphis 4641239, Tennessee 4662168 38104
Contact:
Quentin Thacker
qthacker@uthsc.edu

University of Texas Medical Branch
Galveston 4692883, Texas 4736286 77555
Contact:
Stephanie Simmons
sttsimmo@UTMB.edu

Houston Methodist Hospital
Houston 4699066, Texas 4736286 77030
Contact:
David McCane
dmccane@houstonmethodist.org

Memorial Hermann Texas Medical Center
Houston 4699066, Texas 4736286 77030
Contact:
Ariana Victoria AQUINO HERNANDEZ
Ariana.Victoria.AquinoHernandez@uth.tmc.edu

Covenant Medical Center
Lubbock 5525577, Texas 4736286 79410
Contact:
Katie Hodges
Katie.hodges@covhs.org

Medical City Plano
Plano 4719457, Texas 4736286 75075
Contact:
Syeda Waseem
syeda.waseem@hcahealthcare.com

University of Texas Health Science Center San Antonio
San Antonio 4726206, Texas 4736286 78229
Contact:
Tonya Randolph
randolpht@uthscsa.edu

UT Health Tyler
Tyler 4738214, Texas 4736286 75708
Contact:
Benji Hawkins
benji.hawkins@uthct.edu

UVA Medical Center
Charlottesville 4752031, Virginia 6254928 22903
Contact:
Leo Waters
lxw3rw@uvahealth.org

Inova Fairfax Hospital
Falls Church 4758390, Virginia 6254928 22042
Contact:
Karlie Smith
Karlie.Smith@inova.org

Carilion Roanoke Memorial Hospital
Roanoke 4782167, Virginia 6254928 24011
Contact:
Christina Case
clcase@carilionclinic.org

Swedish Medical Center - Cherry Hill Campus
Seattle 5809844, Washington 5815135 98122
Contact:
Carter Sutherland
Carter.sutherland@swedish.org

More Details

NCT ID
NCT05047172
Status
Recruiting
Sponsor
University of Florida

Study Contact

Stephanie McLaren
888-351-7776
CAPTIVA-Study@ufl.edu

Detailed Description

The proposed study is relevant to public health because narrowing of brain arteries is one of the most common causes of stroke worldwide. Compelling evidence suggests novel antithrombotic medications could reduce the rate of stroke in patients with narrowed brain arteries. The proposed study will directly compare novel antithrombotic medications to standard care antiplatelet medications for preventing stroke and death from vascular causes in patients with narrowed brain arteries.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.